Compare FENC & TDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FENC | TDF |
|---|---|---|
| Founded | 1996 | 1994 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.3M | 301.0M |
| IPO Year | 2001 | N/A |
| Metric | FENC | TDF |
|---|---|---|
| Price | $7.86 | $11.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 118.3K | 79.2K |
| Earning Date | 03-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $38,790,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.78 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.68 | $7.15 |
| 52 Week High | $9.92 | $10.62 |
| Indicator | FENC | TDF |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 47.99 |
| Support Level | $7.65 | $11.51 |
| Resistance Level | $8.11 | $11.71 |
| Average True Range (ATR) | 0.26 | 0.20 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 52.61 | 18.57 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Templeton Dragon Fund Inc is a closed-end management investment company. The fund seeks long-term capital appreciation by investing majority of its total assets in equity securities of China companies. It invests in various sectors such as gas & consumable fuels, auto components, banks, beverages, communications equipment, healthcare equipment & supplies, restaurants & leisure, household durables and many others.